Synthesis of the major metabolites of Paroxetine

Bioorganic Chemistry

Volumn 31, Issue 3, 2003, Pages 248-258

  Segura, Mireia ^a,b   Roura, Lidia ^c,d   De La Torre, Rafael ^a,b   Joglar, Jesús ^c  

^a INST MUNIC D INVESTIGACIO MEDICA   (Spain)

^b UNIVERSITAT POMPEU FABRA   (Spain)

^c DEPARTMENT OF ENVIRONMENTAL CHEMISTRY   (Spain)

^d Soc Espanola Desarrollos Quimicos   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

4 (4 FLUOROPHENYL) 3 (4 HYDROXY 3 METHOXYPHENOXYMETHYL)PIPERIDINE; 4 (4 FLUOROPHENYL) 3 (HYDROXYMETHYL)PIPERIDINE; 4 (4 FLUOROPHENYL) 3 HYDROXYPHENYL 1 METHYLPIPERIDINE; DRUG METABOLITE; PAROXETINE; PIPERIDINE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; DRUG STRUCTURE; DRUG SYNTHESIS; PRIORITY JOURNAL; STEREOCHEMISTRY;

EID: 0038348335     PISSN: 00452068     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0045-2068(03)00040-3     Document Type: Article

References (15)

1. Härtter S., Hermes B., Szegedi A., Hiemke C. Ther. Drug Monit. 16:1994;400-406.
2. Tulloch I.F., Johnson A.M. J. Clin. Psychiatry. 53:1992;7-12.
3. Kaye C.M., Haddock R.E., Langley P.F., Mellows G., Tasker T.C., Zussman B.D., Greb W.H. Acta Psychiatr. Scand., Suppl. 350:1989;60-75.
4. Haddock R.E., Johnson A.M., Langley P.F., Nelson D.R., Pope J.A., Thomas D.R., Woods F.R. Acta Psychiatr. Scand., Suppl. 350:1989;24-26.
5. Gunasekara N.S., Noble S., Benfield P. Drugs. 55:1998;85-120.
6. Dechant K.L., Clissold S.P. Drugs. 41:1991;225-253.
7. Murray M. Curr. Drug Metab. 1:2000;67-84.
8. Ortiz de Montellano P.R., Reich N.O. Ortiz de Montellano P.R. Cytochrome P-450. 1986;280-283 Plenum Press, New York.
9. Yoshida Y., Sakakura Y., Aso N., Okada S., Tanabe Y. Tetrahedron. 55:1999;2183-2192.
10. Barrero A.F., Alvarez-Manzaneda E.J., Chahboun R. Tetrahedron. 54:1998;5635-5650.
11. (a) Christensen, J.A., Squires, R.F., 1973. UK Patent 1,422,263;
12. Christensen, J.A., Squires, R.F., 1977. US Patent 4,007,196.
13. (a) Olofson R.A., Schnur R.C., Bunes L., Pepe J.P. Tetrahedron Lett. 1977;1567-1570;
14. (b) Willcocks K., Barnes R.D., Rusttidge D.C., Tidy D.J.D. J. Labelled Compd. and Radiopharm. 33:1993;783-794.
15. N 2 reaction. This contradiction led us to investigate the relative stereochemical outcome of our reaction.